ARTESUNATE AMIVAS Powder and solvent for solution for injection Ref.[28241] Active ingredients: Artesunate

Source: European Medicines Agency (EU)  Revision Year: 2022  Publisher: Amivas Ireland Ltd, 7 Durands Court, Parnell Street, Waterford, Ireland

Product name and form

Artesunate Amivas 110 mg powder and solvent for solution for injection.

Pharmaceutical Form

Powder and solvent for solution for injection.

Powder: white or almost white, fine crystalline powder.

Solvent: clear and colourless solution.

Qualitative and quantitative composition

Each vial of powder contains 110 mg of artesunate.

Each vial of solvent for reconstitution contains 12 mL of 0.3 M sodium phosphate buffer.

After reconstitution, the solution for injection contains 10 mg of artesunate per mL.

Excipient(s) with known effect:

After reconstitution, the solution for injection contains 13.4 mg sodium per mL.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Artesunate

Artesunate is a semi-synthetic artemisinin derivative, indicated for the initial treatment of severe malaria in adults and children. The antimalarial mechanism of action of artesunate is generally thought to depend upon activation involving iron-mediated cleavage of the endoperoxide bridge of DHA to generate an unstable organic free radical followed by alkylation, where the free radical binds to malarial proteins leading to destruction of parasite membranes.

List of Excipients

Solvent:

Monosodium phosphate monohydrate
Disodium phosphate dihydrate
Phosphoric acid, concentrated (for pH adjustment)
Sodium hydroxide (for pH adjustment)
Water for injections

Pack sizes and marketing

The powder is supplied in a Type I glass vial capped with a latex-free bromobutyl rubber stopper and aluminium seal, containing 110 mg of artesunate.

The solvent is supplied in a Type I glass vial capped with a latex-free bromobutyl rubber stopper and aluminium seal, containing 12 mL of sterile 0.3 M sodium phosphate buffer for reconstitution.

Each pack contains 2 or 4 vials of artesunate powder and 2 or 4 vials of sodium phosphate buffer solvent.

Not all pack sizes may be marketed.

Marketing authorization holder

Amivas Ireland Ltd, 7 Durands Court, Parnell Street, Waterford, Ireland

Marketing authorization dates and numbers

EU/1/21/1582/001
EU/1/21/1582/002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.